An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus
Clinical trial NCT05352919 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05352919
- Sponsor
- Biogen
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-10
- Primary completion
- 2030-03-29
- Enrollment
- 864
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.